Vaccine 92% effective against Delta variant: AstraZeneca
The Delta variant is a key contributor to the current wave of infection in the Indian subcontinent and beyond
The Delta variant is a key contributor to the current wave of infection in the Indian subcontinent and beyond
This is because results of the vaccine's crucial clinical trial in the US are yet to be declared and the company has not yet applied for approval of the vaccine with the US regulators, The New York Times reported.
